Q1 2026 Holdings
Filed 2026-05-14 | 83 holdings | $249.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bioatla Inc(BCAB) | COM | 09077B104 | $10.5K | 65,387 | 0.0% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $39.9K | 16,300 | 0.0% |
| Evaxion AS(EVAX) | SPONSORED ADS | 29970R303 | $73.3K | 19,713 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $88.8K | 40,000 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $107.8K | 35,000 | 0.0% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $117.7K | 20,400 | 0.0% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $134.5K | 50,000 | 0.1% |
| Processa Pharmaceuticals Inc(PCSA) | COM SHS | 74275C403 | $138.9K | 55,000 | 0.1% |
| CNS Pharmaceuticals Inc(CNSP) | COM | 18978H508 | $145.8K | 61,000 | 0.1% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $156.9K | 30,000 | 0.1% |
| SI Bone Inc(SIBN) | COM | 825704109 | $189.0K | 14,964 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $191.5K | 50,000 | 0.1% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $195.0K | 100,000 | 0.1% |
| Compugen LTD(CGEN) | ORD | M25722105 | $222.2K | 104,300 | 0.1% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $232.2K | 40,030 | 0.1% |
| Omniab Inc(OABI) | COM | 68218J103 | $257.6K | 164,045 | 0.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $278.0K | 20,000 | 0.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $283.1K | 224,650 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $291.5K | 27,500 | 0.1% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $312.5K | 68,688 | 0.1% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $315.0K | 35,000 | 0.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $340.7K | 6,000 | 0.1% |
| Quoin Pharmaceuticals LTD(QNRX) | SPONSORED ADS | 74907L409 | $352.8K | 53,460 | 0.1% |
| Precision Optics Corp Inc MA(POCI) | COM NEW | 740294400 | $439.0K | 100,000 | 0.2% |
| Abeona Therapeutics Inc(ABEO)Call | COM NEW | 00289Y206 | $448.0K | 100,000 | 0.2% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $502.3K | 102,500 | 0.2% |
| Verrica Pharmaceuticals Inc(VRCA) | COM SHS | 92511W207 | $527.6K | 99,735 | 0.2% |
| Xilio Therapeutics Inc(XLO) | COM NEW | 98422T209 | $539.6K | 64,162 | 0.2% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $548.9K | 132,578 | 0.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $555.6K | 50,010 | 0.2% |
| Satellos Bioscience Inc(MSLE) | COM | 80401L803 | $563.0K | 100,000 | 0.2% |
| Pasithea Therapeutics Corp(KTTA) | COM NEW | 70261F202 | $616.7K | 831,301 | 0.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $629.7K | 269,100 | 0.3% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $643.5K | 134,060 | 0.3% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $657.5K | 597,682 | 0.3% |
| Codexis Inc(CDXS) | COM | 192005106 | $681.3K | 417,994 | 0.3% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $705.8K | 1,004,673 | 0.3% |
| Radiopharm Theranostics LTD | SPONSORED ADS | 75041J101 | $739.0K | 51,000,000 | 0.3% |
| Heron Therapeutics Inc(HRTX)Call | COM | 427746102 | $800.1K | 1,000,000 | 0.3% |
| Connect Biopharma Hldgs LTD(CNTB) | SHS | G23549101 | $812.2K | 310,000 | 0.3% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $874.5K | 50,000 | 0.4% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $878.0K | 708,102 | 0.4% |
| Ardelyx Inc(ARDX)Call | COM | 039697107 | $898.5K | 150,000 | 0.4% |
| Delcath SYS Inc(DCTH)Call | COM NEW | 24661P807 | $928.0K | 100,000 | 0.4% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $940.0K | 200,000 | 0.4% |
| Cytomx Therapeutics Inc.(CTMX)Call | COM | 23284F105 | $940.0K | 200,000 | 0.4% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $961.4K | 33,005 | 0.4% |
| Neumora Therapeutics Inc.(NMRA)Call | COM | 640979100 | $975.0K | 500,000 | 0.4% |
| In8bio Inc(INAB) | COM NEW | 45674E208 | $981.9K | 663,412 | 0.4% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $991.1K | 768,288 | 0.4% |